{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:06:45Z","timestamp":1774523205622,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"DOI":"10.7759\/cureus.105880","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:23:14Z","timestamp":1774520594000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Myeloid Sarcoma Presenting With Recurrent Ascites: A Case Report"],"prefix":"10.7759","author":[{"given":"Mossaab","family":"El Mousadik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monsif","family":"FADI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoubida","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najat","family":"Lamalmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouama","family":"Bouanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17243975","article-title":"Clinical and molecular characterization of myeloid sarcoma: a systematic review and meta-analysis","volume":"17","author":"Padmanabhan DS","year":"2025","unstructured":"Padmanabhan DS, Aguilar JJ, Nanja Reddy S, et al.. Clinical and molecular characterization of myeloid sarcoma: a systematic review and meta-analysis. Cancers (Basel). 2025, 17:3975. 10.3390\/cancers17243975","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond LM","year":"2017","unstructured":"Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017, 17:263-7. 10.1016\/j.clml.2017.02.027","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969","volume":"31","author":"Liu PI","year":"1973","unstructured":"Liu PI, Ishimaru T, McGregor DH, Okada H, Steer A. Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969. Cancer. 1973, 31:948-55. 10.1002\/1097-0142(197304)31:4&lt;948::AID-CNCR2820310428&gt;3.0.CO;2-N","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman RS","year":"1981","unstructured":"Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, Bennett JM. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer. 1981, 48:1426-37. 10.1002\/1097-0142(19810915)48:6&lt;1426::AID-CNCR2820480626&gt;3.0.CO;2-G","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V35.3.361.361","article-title":"Granulocytic sarcoma (chloroma)","volume":"35","author":"Wiernik PH","year":"1970","unstructured":"Wiernik PH, Serpick AA. Granulocytic sarcoma (chloroma). Blood. 1970, 35:361-9.","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal G","year":"2017","unstructured":"Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017, 7:e592. 10.1038\/bcj.2017.79","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05288-1","article-title":"Myeloid sarcoma: more and less than a distinct entity","volume":"102","author":"Loscocco GG","year":"2023","unstructured":"Loscocco GG, Vannucchi AM. Myeloid sarcoma: more and less than a distinct entity. Ann Hematol. 2023, 102:1973-84. 10.1007\/s00277-023-05288-1","journal-title":"Ann Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.989366","article-title":"Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: a SEER-based study","volume":"12","author":"Xing Z","year":"2022","unstructured":"Xing Z, Zhu X, Li Z, Wang H, Qian M, Zhai X. Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: a SEER-based study. Front Oncol. 2022, 12:989366. 10.3389\/fonc.2022.989366","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst RL","year":"2011","unstructured":"Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011, 118:3785-93. 10.1182\/blood-2011-04-347229","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000444516","article-title":"Myeloid sarcoma of the hepatobiliary system: a case series and review of the literature","volume":"135","author":"Norsworthy KJ","year":"2016","unstructured":"Norsworthy KJ, Bhatnagar B, Singh ZN, Gojo I. Myeloid sarcoma of the hepatobiliary system: a case series and review of the literature. Acta Haematol. 2016, 135:241-51. 10.1159\/000444516","journal-title":"Acta Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/484903","article-title":"Hepatic manifestations in hematological disorders","volume":"2013","author":"Murakami J","year":"2013","unstructured":"Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol. 2013, 2013:484903. 10.1155\/2013\/484903","journal-title":"Int J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1148\/rg.351130008","article-title":"Hematologic malignancies of the liver: spectrum of disease","volume":"35","author":"Tomasian A","year":"2015","unstructured":"Tomasian A, Sandrasegaran K, Elsayes KM, Shanbhogue A, Shaaban A, Menias CO. Hematologic malignancies of the liver: spectrum of disease. Radiographics. 2015, 35:71-86. 10.1148\/rg.351130008","journal-title":"Radiographics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7743","article-title":"Utility of FDG PET\/CT in the assessment of myeloid sarcoma","volume":"198","author":"Lee EY","year":"2012","unstructured":"Lee EY, Anthony MP, Leung AY, Loong F, Khong PL. Utility of FDG PET\/CT in the assessment of myeloid sarcoma. AJR Am J Roentgenol. 2012, 198:1175-9. 10.2214\/AJR.11.7743","journal-title":"AJR Am J Roentgenol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47020111","article-title":"Diagnostic approaches in myeloid sarcoma","volume":"47","author":"Patkowska E","year":"2025","unstructured":"Patkowska E, Krzywdzinska A, Solarska I, Wojtas M, Prochorec-Sobieszek M. Diagnostic approaches in myeloid sarcoma. Curr Issues Mol Biol. 2025, 47:111. 10.3390\/cimb47020111","journal-title":"Curr Issues Mol Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7350","article-title":"Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS","volume":"7","author":"Kanagal-Shamanna R","year":"2016","unstructured":"Kanagal-Shamanna R, Luthra R, Yin CC, et al.. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Oncotarget. 2016, 7:14251-8. 10.18632\/oncotarget.7350","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477538-hepatic-myeloid-sarcoma-presenting-with-recurrent-ascites-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:23:15Z","timestamp":1774520595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477538-hepatic-myeloid-sarcoma-presenting-with-recurrent-ascites-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}